Randomised clinical trial: efficacy and safety of the live biotherapeutic product MRx1234 in patients with irritable bowel syndrome.
Eamonn M M QuigleyLouise MarkinsonAlex StevensonF Peter TreasureBrian E LacyPublished in: Alimentary pharmacology & therapeutics (2022)
gov #NCT03721107.